Selective chemokine mRNA expression following brain injury

• Published in: Brain research Vol. 788; no. 1; pp. 49 - 59
• Main Authors: Hausmann, Elda H.S, Berman, Nancy E.J, Wang, Yu-Ying, Meara, J.Brad, Wood, Gary W, Klein, Robert M
• Format: Journal Article
• Language: English
• Published: London Elsevier B.V 30.03.1998; Amsterdam Elsevier; New York, NY
• Subjects: Animals; Biochemistry and metabolism; Biological and medical sciences; Brain Injuries - metabolism; Brain injury; Central nervous system; Cerebral Cortex - drug effects; Cerebral Cortex - injuries; Cerebral Cortex - metabolism; Chemokine; Chemokines - genetics; Cortical lesion; Cytokine; Fundamental and applied biological sciences. Psychology; Lipopolysaccharides; Mice; Mice, Inbred Strains; mRNA; RNA, Messenger - biosynthesis; Sterilization; Vertebrates: nervous system and sense organs; Chemokine; mRNA; Cortical lesion; Brain injury; Cytokine; Vertebrata; Cerebral cortex; Mammalia; Mouse; Rodentia; Central nervous system; Lesion; Gene expression; Brain (vertebrata)
• ISSN: 0006-8993; 1872-6240
• DOI: 10.1016/S0006-8993(97)01160-8

Injury in non-neuronal tissues stimulates chemokine expression leading to recruitment of inflammatory cells responsible for orchestration of repair processes. The signals involved in directing repair of damage to the brain are less well understood. We hypothesized that following brain injury, chemokines are expressed and regulate the rate and pattern of inflammatory cell accumulation. The two chemokine subfamilies are alpha( α)-chemokines, which primarily function as neutrophil chemoattractants, and the beta( β)-chemokines, which function primarily as monocyte chemoattractants. We assessed α and β chemokine mRNA expression patterns and leukocyte accumulation following a cerebral cortical lesion. Cortical lesions were produced with and without addition of endotoxin, Escherichia coli lipopolysaccharide (LPS), which stimulates cytokine expression. We studied the expression of the β-chemokines: monocyte chemoattractant protein (gene product JE; MCP-1/JE), macrophage inflammatory protein-1 alpha and beta (MIP-1 α and MIP-1 β), and the regulated upon activation normal T expressed and secreted chemokine (RANTES) as well as the α-chemokines: interferon- γ-inducible protein (IP-10) and N51/KC (KC; a murine homologue of MIP-2). Changes in gene expression were analyzed by northern analysis at different time points following injury. Leukocyte and macrophage densities were analyzed by immunohistochemistry at the same time intervals. All chemokines were elevated following cortical injury/endotoxin. MCP-1 and MIP-1 α were elevated at 2 h and peaked 6 h, MIP-1 β peaked at 6 h, but declined more rapidly than MCP-1 or MIP-1 α, and IP-10 peaked at 6 h and showed the most rapid decline. KC was elevated at 1 h, and peaked at 6 h following LPS. RANTES was elevated at 1 h and achieved a plateau level between 6 and 18 h, then declined. In contrast, sterile injuries produced in the absence of endotoxin only induced the mRNA of the β-chemokine MCP-1, and its expression was delayed compared to the cortical injury/endotoxin group. The presence of chemokine message as early as 1 h indicates that expression of this class of molecules is an early response in the repair process following traumatic brain injury. Macrophage/microglia accumulation occurred more rapidly, activated microglia further from the lesion border, and more cells accumulated in cortical injury/endotoxin than in cortical lesions produced under sterile conditions. Thus, there was a positive correlation between β-chemokine expression and the number of β-chemokine responsive cells (i.e. microglia) accumulating in injury sites. This is the first comprehensive study using a panel of chemokine probes and specific marcophage/microglial markers to study in vivo activation of the brain following injury. Our data show that the brain is capable of expression of multiple chemokine genes upon appropriate stimulation (e.g. LPS-treatment). The gradient of microglial activation is consistent with physical damage stimulating release of chemokines that diffuse from the injury site. These data strongly suggest that chemokines are instrumental in the initiation of repair processes following brain injury.